IL52615A0 - Novel 1,5-disubstituted-2-pyrrolidones,their production and pharmaceutical compositions containing them - Google Patents

Novel 1,5-disubstituted-2-pyrrolidones,their production and pharmaceutical compositions containing them

Info

Publication number
IL52615A0
IL52615A0 IL52615A IL5261577A IL52615A0 IL 52615 A0 IL52615 A0 IL 52615A0 IL 52615 A IL52615 A IL 52615A IL 5261577 A IL5261577 A IL 5261577A IL 52615 A0 IL52615 A0 IL 52615A0
Authority
IL
Israel
Prior art keywords
pyrrolidones
disubstituted
novel
production
pharmaceutical compositions
Prior art date
Application number
IL52615A
Other versions
IL52615A (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL52615A0 publication Critical patent/IL52615A0/en
Publication of IL52615A publication Critical patent/IL52615A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL52615A 1976-08-06 1977-07-28 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them IL52615A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
IL52615A0 true IL52615A0 (en) 1977-10-31
IL52615A IL52615A (en) 1981-09-13

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52615A IL52615A (en) 1976-08-06 1977-07-28 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them

Country Status (31)

Country Link
JP (2) JPS5321159A (en)
AR (1) AR217080A1 (en)
AT (1) AT362887B (en)
AU (1) AU508007B2 (en)
BE (1) BE857506A (en)
BG (1) BG31073A3 (en)
CA (1) CA1077948A (en)
CH (1) CH624934A5 (en)
CS (1) CS221269B2 (en)
DD (2) DD143768A5 (en)
DE (1) DE2735904A1 (en)
DK (1) DK352077A (en)
ES (2) ES461388A1 (en)
FI (1) FI70009C (en)
FR (1) FR2369260A1 (en)
GB (2) GB1556569A (en)
GR (1) GR68688B (en)
HU (1) HU180273B (en)
IE (1) IE45505B1 (en)
IL (1) IL52615A (en)
LU (1) LU77936A1 (en)
NL (1) NL7708637A (en)
NO (1) NO772752L (en)
NZ (1) NZ184806A (en)
PH (1) PH17398A (en)
PL (2) PL200124A1 (en)
PT (1) PT66891B (en)
SE (1) SE423813B (en)
SU (3) SU703016A3 (en)
YU (1) YU192577A (en)
ZA (1) ZA774704B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (en) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp Feed voltage compensator for electric railroad
PT1132086E (en) 2000-01-31 2006-09-29 Pfizer Prod Inc USE OF SELECTIVE AGONISTS FOR THE PROSTAGLANDINE (PGE2) 4 (EP4) RECEPTOR FOR THE TREATMENT OF ACUTE AND CHRONIC RENAL FAILURE
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
EP1339678B1 (en) * 2000-11-27 2007-09-26 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
IL159996A0 (en) * 2001-07-23 2004-06-20 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
ES2268327T3 (en) * 2002-03-18 2007-03-16 Pfizer Products Inc. USE OF A SELECTIVE OF AN EP4 RECEIVER FOR THE TREATMENT OF DISEASES.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US7256211B1 (en) * 2003-01-21 2007-08-14 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (en) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22PIRORIDONJUDOTAINO SEIHO
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (en) * 1975-06-27 1977-01-13 Hoechst Ag PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Also Published As

Publication number Publication date
PL200124A1 (en) 1978-05-22
JPS585196B2 (en) 1983-01-29
FI70009B (en) 1986-01-31
SE7708642L (en) 1978-02-07
NZ184806A (en) 1980-04-28
NL7708637A (en) 1978-02-08
IL52615A (en) 1981-09-13
AT362887B (en) 1981-06-25
AU508007B2 (en) 1980-03-06
PT66891B (en) 1979-01-26
IE45505L (en) 1978-02-06
JPS5555161A (en) 1980-04-22
CH624934A5 (en) 1981-08-31
AU2751577A (en) 1979-02-08
GB1556570A (en) 1979-11-28
LU77936A1 (en) 1978-04-27
PT66891A (en) 1977-09-01
FR2369260A1 (en) 1978-05-26
SE423813B (en) 1982-06-07
GR68688B (en) 1982-02-01
ATA579477A (en) 1980-11-15
DE2735904A1 (en) 1978-02-09
HU180273B (en) 1983-02-28
GB1556569A (en) 1979-11-28
JPS5321159A (en) 1978-02-27
NO772752L (en) 1978-02-07
JPS5531147B2 (en) 1980-08-15
ZA774704B (en) 1978-06-28
PH17398A (en) 1984-08-08
DD136135A5 (en) 1979-06-20
ES471349A1 (en) 1979-09-16
SU818480A3 (en) 1981-03-30
BE857506A (en) 1978-02-06
CS221269B2 (en) 1983-04-29
BG31073A3 (en) 1981-10-15
PL112931B1 (en) 1980-11-29
SU703016A3 (en) 1979-12-05
ES461388A1 (en) 1978-12-01
FR2369260B1 (en) 1982-02-12
DK352077A (en) 1978-02-07
DD143768A5 (en) 1980-09-10
AR217080A1 (en) 1980-02-29
FI70009C (en) 1986-09-12
YU192577A (en) 1983-04-30
CA1077948A (en) 1980-05-20
FI772376A (en) 1978-02-07
IE45505B1 (en) 1982-09-08
SU850000A3 (en) 1981-07-23

Similar Documents

Publication Publication Date Title
IL55423A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
IL53533A (en) Tetralin derivatives,their production and pharmaceutical compositions containing them
IL55382A0 (en) Novel propenylamines, their production and pharmaceutical compositions containing them
IL51945A (en) Substituted n-cinnamyl-n-naphthylmethyl amines,their production and pharmaceutical compositions containing them
IL51840A0 (en) Trans-hexahydro-pyrido-indoles their production and pharmaceutical compositions containing them
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
IL51966A0 (en) Novel aminopiperidines their production and pharmaceutical compositions incorporating them
IL60037A (en) Pyrazinobenzodiazepines,their production and pharmaceutical compositions containing them
IL52615A0 (en) Novel 1,5-disubstituted-2-pyrrolidones,their production and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL53332A (en) 3-fluoro-6-piperazino-morphanthridine derivatives,their production and pharmaceutical compositions containing them
IL55207A0 (en) Novel benzodiazepine-diones,their production and pharmaceutical compositions containing them
IL54105A0 (en) Novel benzylpyrimidines, their production and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
IL51981A0 (en) Novel 1,2,6-thiadiazinones their production and compositions containing them
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
IL61773A0 (en) Pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
IL53013A0 (en) 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them
IL55869A (en) 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
IL56696A (en) N1-glucofuranosid-6-yl-n3-nitroso-ureas,their production and pharmaceutical compositions containing them
JPS5394028A (en) Pharmaceutical composition and production thereof
IL50554A0 (en) Novel 2,9-dioxatricyclodecanes their preparation and pharmaceutical compositions containing them
IL54342A (en) 2,3 -dihydroergolen-8 -ylmethylurea derivatives, their production and pharmaceutical compositions containing them
IL53120A (en) 1,2,3,4-tetrahydro-9h-pyrrolo(3,4-b)quinolin-9-one derivatives,their production and pharmaceutical compositions containing them
IL48527A0 (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,their manufacture and pharmaceutical compositions containing them